Evaluation of in vitro Antiviral Activity in Methanol Extracts against Influenza Virus Type A from Korean Medicinal Plants

Phytotherapy Research

Volumn 17, Issue 9, 2003, Pages 1059-1063

  Park, Kap Joo ^a  

^a Konkuk University   (South Korea)

Author keywords

Haemagglutination inhibition test; Influenza virus; Korean medicinal plants; Methanol extracts

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; HERBACEOUS AGENT; METHANOL; MM 104; MM 110; MM 57; MM 72; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DRUG SCREENING; EMBRYO; ERYTHROCYTE; HEMAGGLUTINATION INHIBITION; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS A; KOREA; MEDICINAL PLANT; NONHUMAN; VIRUS ADSORPTION; VIRUS INHIBITION;

ANTIVIRAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; KOREA; MEDICINE, TRADITIONAL; MICROBIAL SENSITIVITY TESTS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL;

INFLUENZA A VIRUS; INFLUENZA VIRUS;

EID: 0242300103     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1330     Document Type: Article

References (13)

1. Boivin G, Goyette N. 2002. Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors. Antiviral Res 54: 143-147.
2. Brock TD, Madigan MT, Marrtinko JM, Parker I. 1997. Biology of Microorganisms: Influenza virus 7th edn. Prentice-Hall: Upper Saddle River, NJ.
3. Huh J. 1981. Young-In Bon Dong Eu Bo Gam. Hang-Sung Book Press (Korean traditional medicine book): Seoul.
4. Ikeda SJ, Neyts J, Verma S, Wickramasinghe A, Mohan P, De Clercq E. 1994. In vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusion. Antimicrob Agents Chemother 38: 256-259.
5. Kent IH, Chapman LE, Schmelts LM, Regnery HL, Cox NJ, Schonberger LB. 1991-1992. Influenza surveillance-United States. Morb Mortal Wkly Rep CDC Surveill Summ 41: 35-46.
6. Klenk HD, Rott R. 1988. The molecular biology of influenza virus pathogenicity. Adv Virus Res 34: 247-281.
7. Laver WG. 1973. The polypeptides of influenza viruses. Adv Virus Res 18: 57-103.
8. Lee S-K, Cho H-K. 1985. Effects of saponin of ginseng on the formation of lipid of Rhodotorula glutinis. Kor J Appl Microbiol Biotechnol 13: 109-114.
9. McLaren LC. 1992. Clinical virology manual. In Hemagglutination Inhibition and Hemadsorption, Specter S et al. (eds). Elsevier Science Publishing: New York; 243-249.
10. Schulze IT. 1973. Structure of the influenza virion. Adv Virus Res 18: 1-55.
11. Shaw MW, Arden NH, Maassab HF. 1992. New aspects of influenza viruses. Clin Microbiol Rev 1: 74-92.
12. Taylor RSL, Manandahar NP, Hudson JB, Towers GHN. 1996. Antiviral activities of Nepalese medicinal plants. J Ethnopharmacol 52: 157-164.
13. Yoon K-Y. 1992. Clinical Prescriptions of Korean Traditional Medical Books. Myung Bo Publishing: Seoul, Korea.